The purpose of this study is to evaluate efficacy and safety of pregabalin in the treatment of postherpetic neuralgia in a dose-ranging manner.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Mean Pain Scores at Endpoint
Timeframe: Week13/discontinuation
Mean Pain Score at Endpoint by Groups of Subjects With Expected Similar Plasma Concentrations
Timeframe: Week13/discontinuation
Number of Responders
Timeframe: Week13/discontinuation
Mean Pain Scores at Week 1
Timeframe: Week 1
Mean Pain Scores at Week 2
Timeframe: Week 2
Mean Pain Scores at Week 3
Timeframe: Week 3
Mean Pain Scores at Week 4
Timeframe: Week4
Mean Pain Scores at Week 5
Timeframe: Week 5
Mean Pain Scores at Week 6
Timeframe: Week 6
Mean Pain Scores at Week 7
Timeframe: Week 7
Mean Pain Scores at Week 8
Timeframe: Week 8
Mean Pain Scores at Week 9
Timeframe: Week 9
Mean Pain Scores at Week 10
Timeframe: Week 10
Mean Pain Scores at Week 11
Timeframe: Week 11
Mean Pain Scores at Week 12
Timeframe: Week 12
Mean Pain Scores at Week 13
Timeframe: Week 13